In contrast, it has been observed that in wild-type mice fed a high-fat diet, low concentrations of bromocriptine can prevent obesity-induced glucose intolerance through peripheral, but not central, orexin-mediated mechanisms [119]. Here, HCRT is linked to obesity disorder.